STOCK TITAN
  1. Home
  2. Sec-filings
  3. GALT
  4. [Form 4] Galectin Therapeutics Inc. Insider Trading Activity

[Form 4] Galectin Therapeutics Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock GALT logo
Galectin Therapeutics Inc

NASDAQ:GALT

GALT Rankings

#3884 Ranked by Market Cap
N/A Ranked by Dividends

GALT Latest News

Sep 2, 2025
Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Aug 14, 2025
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2025 and Provides Business Update
Jul 9, 2025
Galectin Therapeutics Announces New $10 Million Credit Line from Richard E. Uihlein, Sufficient to Cover Expected Expenditures Through June 2026
Jun 10, 2025
Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension
May 15, 2025
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2025 and Provides Business Update

GALT Latest SEC Filings

Aug 14, 2025
[8-K] Galectin Therapeutics Inc. Reports Material Event
Aug 14, 2025
[10-Q] Galectin Therapeutics Inc. Quarterly Earnings Report
Jul 22, 2025
[Form 4] Galectin Therapeutics Inc. Insider Trading Activity
Jul 9, 2025
[8-K] Galectin Therapeutics Inc. Reports Material Event

GALT Stock Data

274.18M
44.47M
30.08%
16.35%
12.18%
Biotechnology
Pharmaceutical Preparations
Link
United States
NORCROSS